ClinicalTrials.gg
RecruitingNCT06190171Updated Sep 21, 2026

Respiratory Strength Training in Heart Transplant Recipients

An interventional study of Active respiratory muscle strength training and Sham respiratory muscle strength training in Dysphagia and Heart Transplant Recipients, sponsored by Vanderbilt University Medical Center. Recruiting at 1 site in United States. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-09-21.

Sponsored by Vanderbilt University Medical Center · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started May 2024; still recruiting 2 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

This research study is investigating whether completing breathing exercises before surgery helps heart transplant patients recover after surgery. Previous studies have shown that breathing exercises can improve breathing, cough, and swallow function in patients with other diseases/conditions. The current study will investigate the impact of a preoperative respiratory muscle strength training program on breathing and cough function, swallow function, patient-reported eating and swallowing fatigue, and health outcomes in individuals undergoing heart transplantation.

Participants will:

  • undergo tests of breathing, cough, and swallow function
  • complete questionnaires about the treatment, their swallow function
  • complete breathing exercises daily
Read the detailed description

This study will involve three in-person research evaluations to our lab or in the hospital that will last 45 minutes- 1 hour and will consist of a screening, breathing and cough testing, swallow function testing, and completion of questionnaires. Following the initial research evaluation, individuals will complete daily exercises of active or sham respiratory muscle strength training for several weeks with one telehealth or in-person session per week. The exercises will take 10-15 minutes to complete, and individuals will fill out training logs daily. Prior to transplantation and after completion of the breathing exercises, individuals will undergo a second research evaluation. Then, following surgery, individuals will undergo a third research evaluation and outcomes will be tracked via the electronic health records system.

02

Conditions studied

  • Dysphagia
  • Heart Transplant Recipients

Keywords

  • dysphagia
  • deglutition
  • deglutition disorders
  • swallowing
  • breathing
  • cough
  • swallowing disorders
  • heart transplant recipients
  • respiratory muscle strength training
03

In context

Deglutition Disorders

871 studies on the registry are indexed under Deglutition Disorders; 237 are open to participants now.

This study's planned enrollment of 90 is above the median of 60 across 578 interventional studies indexed under Deglutition Disorders.

Browse Deglutition Disorders studies →

Lead sponsor

Vanderbilt University Medical Center is the lead sponsor of 833 studies on the registry; 155 are open to participants now.

Of its 125 completed or terminated interventional studies of FDA-regulated products, 92 (74%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Adult (18-90 years old)
  2. Not pregnant
  3. Undergoing evaluation or actively waitlisted for heart transplantation at VUMC with a waitlist status of 1-6
  4. Have a computer, tablet or electronic device with a stable internet connection for telehealth sessions (outpatient)
  5. Be willing to undergo testing procedures and complete the exercise training program.

Exclusion criteria

Exclusion Criteria:

  1. Individual \<18 years old, >90 years old
  2. Pregnant
  3. No access to a computer, tablet or electronic device with a stable internet connection for telehealth sessions
  4. Unwilling or unable to undergo testing procedures and complete the exercise training program.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Active respiratory muscle strength training

    Enrolled heart transplant patients will undergo active preoperative respiratory strength training using two respiratory strength training devices from enrollment until they receive a heart transplant.

    Device: Active respiratory muscle strength training

  • Sham comparator
    Sham respiratory muscle strength training

    Enrolled heart transplant patients will undergo sham preoperative respiratory strength training using two respiratory strength training devices from enrollment until they receive a heart transplant. For individuals completing sham respiratory strength training, the spring will be removed from the devices as has been done in prior sham-controlled trials.

    Device: Sham respiratory muscle strength training

Interventions

  • DeviceActive respiratory muscle strength training

    Devices will be set to 60% of participants' maximum expiratory pressure and maximum inspiratory pressure. Participants will complete training 7 days per week by performing 5 sets of 5 repetitions for both expiratory and inspiratory muscle strength training (a total of 50 repetitions).

  • DeviceSham respiratory muscle strength training

    Springs will be removed from devices to ensure training is done without resistance. Participants will complete training 7 days per week by performing 5 sets of 5 repetitions for both expiratory and inspiratory sham muscle strength training (a total of 50 repetitions).

06

What researchers measure

Primary outcomes

  1. Change in maximum expiratory pressure between pre and post respiratory strength training

    A measure of respiratory strength while breathing out

    Time frame: baseline, post-intervention/pre-surgery (an average of 2-6 weeks after baseline)

  2. Change in maximum inspiratory pressure between pre and post respiratory strength training

    A measure of respiratory strength while breathing in

    Time frame: baseline, post-intervention/pre-surgery (an average of 2-6 weeks after baseline)

Secondary outcomes

  1. Change in cough peak expiratory flow between pre and post respiratory strength training

    A measure of cough strength

    Time frame: baseline, post-intervention/pre-surgery (an average of 2-6 weeks after baseline)

  2. Patient-reported treatment burden

    Patients will complete the exercise therapy burden questionnaire (ETBQ). Scores on the ETBQ range from 0-100 with higher scores indicating greater burden.

    Time frame: post-intervention/pre-surgery (an average of 2-6 weeks after baseline)

  3. Patient reported swallow function

    Patients will complete the swallowing and eating related fatigue (SERF) questionnaire. Scores on the SERF range from 0-48 with higher scores indicating greater impairment.

    Time frame: pre-surgery (baseline), post-surgery

  4. Change in penetration-aspiration scale scores between before and after surgery

    The penetration aspiration scale is a validated 8-point ordinal rating scale that measures the depth of airway invasion and the patient's response during swallowing. Scores range from 1 to 8 with a score of 1 indicating a safe swallow (best score) and 8 indicating silent aspiration (worst score).

    Time frame: pre-surgery (baseline), post-surgery

  5. Change in clinical frailty scale score

    The Clinical Frailty Scale (CFS) is a measure of physical function. Scores on the CFS range from 1-9 with higher scores indicating greater impairment.

    Time frame: baseline, post-intervention/pre-surgery (an average of 2-6 weeks after baseline)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06190171
Responsible party
Cara Donohue, Ph.D. CCC-SLP (Assistant Professor, Director of Medical Speech-Language Pathology, Vanderbilt University Medical Center) — Principal investigator
First posted
Jan 5, 2024
Start date
May 17, 2024
Primary completion
Feb 1, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Sep 21, 2026

Study contacts

Cara Donohue, Ph.D.
Contact
cara.donohue@vumc.org
615-852-5085
Cara Donohue, Ph.D.
principal investigator · Vanderbilt University Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion